Comparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemics
dc.contributor.author | Leonard, Charles E. | |
dc.contributor.author | Han, Xu | |
dc.contributor.author | Bilker, Warren B. | |
dc.contributor.author | Flory, James H. | |
dc.contributor.author | Brensinger, Colleen M. | |
dc.contributor.author | Flockhart, David A. | |
dc.contributor.author | Gagne, Joshua J. | |
dc.contributor.author | Cardillo, Serena | |
dc.contributor.author | Hennessy, Sean | |
dc.contributor.department | Department of Medicine, IU School of Medicine | en_US |
dc.date.accessioned | 2017-08-14T18:53:35Z | |
dc.date.available | 2017-08-14T18:53:35Z | |
dc.date.issued | 2016-05 | |
dc.description.abstract | We conducted high-dimensional propensity score-adjusted cohort studies to examine whether thiazolidinedione use with a statin or fibrate was associated with an increased risk of severe hypoglycemia. We found that concomitant therapy with a thiazolidinedione+fibrate was associated with a generally delayed increased risk of severe hypoglycemia. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Leonard, C. E., Han, X., Bilker, W. B., Flory, J. H., Brensinger, C. M., Flockhart, D. A., … Hennessy, S. (2016). Comparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemics. Diabetes Research and Clinical Practice, 115, 60–67. http://doi.org/10.1016/j.diabres.2016.03.006 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/13824 | |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | 10.1016/j.diabres.2016.03.006 | en_US |
dc.relation.journal | Diabetes Research and Clinical Practice | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Cohort studies | en_US |
dc.subject | Comparative effectiveness research | en_US |
dc.subject | Diabetes mellitus | en_US |
dc.subject | Drug interactions | en_US |
dc.subject | Hypoglycemia | en_US |
dc.subject | Hypolipidemic agents | en_US |
dc.subject | Medicaid | en_US |
dc.subject | Pharmacoepidemiology | en_US |
dc.subject | Propensity score | en_US |
dc.subject | Thiazolidinediones | en_US |
dc.title | Comparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemics | en_US |
dc.type | Article | en_US |